4//SEC Filing
Stewart Christopher P. 4
Accession 0001209191-20-049303
CIK 0001411690other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 12:53 PM ET
Size
8.5 KB
Accession
0001209191-20-049303
Insider Transaction Report
Form 4
Stewart Christopher P.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-09-01+225,000→ 225,000 totalExercise: $0.56Exp: 2030-09-01→ Common Stock (225,000 underlying) - Award
Stock Option (Right to Buy)
2020-09-01+350,000→ 350,000 totalExercise: $0.56Exp: 2030-09-01→ Common Stock (350,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to the stock option vest and become exercisable on September 1, 2021, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such applicable vesting date and the terms of the Issuer's 2020 Inducement Plan, subject to acceleration of vesting as provided for in that certain Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person.
- [F2]The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person.
Documents
Issuer
Bionano Genomics, Inc
CIK 0001411690
Entity typeother
Related Parties
1- filerCIK 0001822991
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 12:53 PM ET
- Size
- 8.5 KB